Concepedia
Biochemical Pharmacology · 1988 · 12 citations · 23 references
Open access
MedicinePharmacologyBone MetabolismCellular PharmacologyDrug MetabolismBone Marrow MicroenvironmentBone Marrow PhysiologyBone Marrow InflammationBone Marrow ProcessingMarrow Response To Injury
23
Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.
George Weber · PubMed · 1983 · 548 citations
Medicine, Oncology, Pharmacology +17
2-.beta.-D-ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases
R. K. ROBINS, Prem C. Srivastava, V. L. Narayanan et al. · Journal of Medicinal Chemistry · 1982 · 147 citations
Medicine, Oncology, Pharmacology +5
Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-d-ribofuranosylthiazole-4-carboxamide NSC 286193)
Hiremagalur N. Jayaram, Robert L. Dion, Robert I. Glazer et al. · Biochemical Pharmacology · 1982 · 144 citations
Medicine, Medicinal Chemistry, Oncology +9
The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties
David A. Cooney, Hiremagalur N. Jayaram, Gulilat Gebeyehu et al. · Biochemical Pharmacology · 1982 · 122 citations
Life Sciences, Biochemistry, Medicinal Chemistry +11
Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide).
May S. Lui, Mary A. Faderan, J. J. Liepnieks et al. · Journal of Biological Chemistry · 1984 · 114 citations · Full text
Medicine, Oncology, Pharmacology +13